VACC

Vaccitech plc VACC

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VACC LSB THRX SPPI ZVRA TCRT LENZ FSTX CRGX SLRN
6M 103.25 % -51.02 % 38.74 % 31.75 % -5.14 % -29.43 % -41.77 % 16.15 % 17.63 % -27.94 %
YTD 108.33 % -82.63 % 1.63 % 167.97 % -0.91 % 75.89 % -38.71 % 15.40 % -70.30 % -31.21 %
1Y 117.39 % -78.38 % -47.95 % -10.87 % 1.05 % 76.79 % -44.95 % 100.00 % -81.53 % -42.96 %
3Y -64.54 % -99.37 % -78.12 % -75.65 % 110.68 % -95.40 % 29.02 % 667.24 % -69.24 % -87.39 %
5Y -64.54 % -99.34 % -78.12 % -95.47 % -24.65 % -99.20 % -80.20 % -49.50 % -69.24 % -87.39 %
10Y -64.54 % -99.34 % -78.12 % -86.62 % -97.19 % -99.73 % -80.20 % -35.86 % -69.24 % -87.39 %
From the beginning -64.54 % -99.34 % -78.12 % -99.25 % -95.16 % -99.86 % -80.20 % -35.86 % -69.24 % -87.39 %

Dividend

Theseus Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

LENZ Therapeutics, Inc.